Supreme Court Upholds FDA Regulation on Popular Abortion Drug Mifepristone
On June 13, the Supreme Court ruled against a group of doctors who challenged the Food and Drug Administration's (FDA) regulations on the abortion pill mifepristone. CBS reports that the case once again highlighted abortion access following the conservative majority decision to overturn Roe v. Wade in 2022.